Katie Sinderson, a BLB&G partner, focuses her practice on advising and representing the firm’s institutional investor clients in securities fraud class actions. With more than 18 years of practice experience, she has led litigation teams that have recovered billions of dollars for investors harmed by corporate fraud and malfeasance. She practices out of the firm’s New York office.
Katie played a key role in two of the firm’s largest cases, both of which settled near trial for billions of dollars on behalf of investors:
- In re Bank of America Securities Litigation: Katie was an integral member of the trial team that prosecuted the securities fraud action against Bank of America related to the company’s acquisition of Merrill Lynch & Co., achieving a recovery of $2.425 billion—one of the top seven U.S. securities class action recoveries of all time.
- In re Merck Securities Litigation: Katie was a leader of the trial team that achieved a $1.062 billion recovery in the action arising from Merck’s marketing of the recalled drug Vioxx—one of the top 13 U.S. securities class action recoveries of all time.
Her recent significant litigation wins include:
- In re Kraft Heinz Securities Litigation: Leading the team that recovered $450 million in the securities class action involving Kraft Heinz and Brazilian private equity firm 3G Capital.
- In re Washington Mutual, Inc., Securities Litigation: Leading the prosecution against Washington Mutual and certain of its former officers and directors for alleged fraudulent conduct in the company’s home lending operations, an action which was resolved for $216.75 million.
- In re Wilmington Trust Securities Litigation: Serving as lead partner in the securities class action arising from the failure of major mid-Atlantic bank Wilmington Trust, achieving a $210 million recovery.
- In re Salix Pharmaceuticals, Ltd. Securities Litigation: Obtaining a $210 million recovery for investors in the securities fraud class action against Salix Pharmaceuticals arising from misrepresentations concerning the wholesaler inventory levels of several of Salix’s most successful products.
- San Antonio Fire and Police Pension Fund et al. v. Dole Food Co. et al.: Resolving an innovative case on behalf of sellers of Dole Food securities, where plaintiffs alleged that Dole’s CEO issued misrepresentations to drive the price of the company down in order to take the company private on the cheap. BLB&G resolved the Dole case for $74 million.
In addition to her litigation responsibilities, Katie co-chairs the Federal Bar Council Securities Litigation Committee. She is also committed to educating clients and the greater investment and legal communities on topics related to securities litigation and women in law. She has served as a guest lecturer at Columbia University and regularly speaks at Practising Law Institute’s “Expert Witness” programs, among other webinars, seminars, and conferences.
Katie is widely recognized in the market for her litigation work. In 2024, Chambers ranked Katie as one of the top plaintiff securities litigators in New York. She has been named a “Litigation Trailblazer” by The National Law Journal, a “Next Generation Partner” by The Legal 500, a “Titan of the Plaintiffs Bar” and “Rising Star” by Law360, a “Rising Star” by the New York Law Journal, and a “Future Star” by Benchmark Litigation. For six straight years, Katie was named to Benchmark Litigation’s “40 & Under List.” In 2024, Lawdragon named Katie one of the “500 Leading Lawyers in America,” and the publication regularly lists Katie as a “Leading Plaintiff Financial Lawyer.” She is regularly selected as a New York “Rising Star” by Thomson Reuters’ Super Lawyers.
Katie received her J.D., cum laude, from the Georgetown University Law Center, where she was a Dean’s Scholar Full Scholarship Award recipient and served as Articles Editor for The Georgetown Journal of Gender and the Law. She received her B.A., cum laude, from Baylor University, where she received the Regents Full Scholarship Award.